During the past decade, Mds Pharma Services (Us), Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mds Pharma Services (Us), Inc" are "Alzheimer Disease" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Mds Pharma Services (Us), Inc" in a lesser frequency.

Most popular intervention types in "Mds Pharma Services (Us), Inc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BMS-708163" (1 trials), "BMS-790052" (1 trials), "Moxifloxacin" (1 trials), "Ortho Tri-Cyclen®" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mds Pharma Services (Us), Inc" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mds Pharma Services (Us), Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mds Pharma Services (Us), Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mds Pharma Services (Us), Inc, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".